Dyslipidemia management in ayurveda with dhamasa churna capsules

Effect of dhamasa (Fagonia arabica Linn) churna in the management of dyslipidemia w.s.r to medodushti-An open labelled clinical trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086409

Enrollment

Registered

2025-05-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Individuals of Either sex between age group 20 to 60 years of age, BMI More than 25, If any of the following levels of lipid profile criteria fulfills LDL - 130 - 159mg/dl, Triglycerides - 150 - 199mg/dl, Total Cholesterol - 200 - 239mg/dl.

Exclusion criteria

Exclusion criteria: Individuals of age group below 20 and above 60 and having BMI below 25, LDL - greater than 159mg/dl, Triglycerides greater than 199mg/dl, Total cholesterol greater than 239mg/dl and suffering from systemic disorders like Hypertension, diabetes mellitus, Kidney disease, Genetic disorders, Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Dhamasa Choorna is expected to be effective in Reducing Increased lipid profile levelTimepoint: assessed on 0th day and on 42ndday i.e, on 1st week and on 6th week	—

Secondary

Measure	Time frame
Decrease in BMITimepoint: 0th, 21st, 42nd days	—

Countries

India

Contacts

Public ContactDr Arun Chougale

KAHERs SHRI BMK Ayurveda Mahavidyalaya

punarjeevam@gmail.com9964749993

Outcome results